Home › Free Stock Grades › DXCM
DexCom, Inc. (DXCM) Stock Grade
DXCM · Healthcare
A+
Market Cap
$33.9B
P/E Ratio
31.0
Revenue Growth (YoY)
+15.6%
Net Margin
17.9%
Return on Equity
30.5%
Dividend Yield
None
About DexCom, Inc.'s fundamentals
DexCom is a large-cap healthcare company with a market capitalization of $25.9 billion that generates solid profitability with a net margin of 17.9% and exceptional shareholder returns at 30.5% ROE. The company is growing revenue at a healthy 15.6% year-over-year pace while trading at a P/E ratio of 31.0, which reflects a premium valuation relative to its current earnings. The company does not currently pay a dividend, focusing instead on reinvestment and growth initiatives.